National Heart, Lung and Blood Institute (NHLBI)

133 Protocols (84 Active Accrual of new subjects, 49 Follow-up of previously enrolled subjects)

 05-H-0088:

Evaluation of the Mechanism of NO Formation and Pharmacokinetics of Systemic Nitrite Infusion

 05-H-0016:

Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease

 04-H-0213:

Cytokine Gene Polymorphisms in Bone Marrow Failure

 04-H-0198:

A Pilot Trial of an Accelerated Immunization Schedule with ALVAC-pp65 (vCP260) for Inducing CMV-Specific Immunity in Stem Cell Allotransplant Donors and Healthy Volunteers

 04-H-0179:

Peripheral Blood Hematopoietic Progenitor Cell Mobilization Using Granulocyte Colony Stimulating Factor (G-CSF) Combined With AMD3100 in Healthy Volunteers

 04-H-0143:

Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication

 04-H-0112:

Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Peritransplant Cyclosporine on Chimerism

 04-H-0090:

A Pilot Study of the Safety and Efficacy of Imatinib in Reducing Monocytosis or Leukocytosis in Patients with Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia, Respectively

 03-H-0312:

Dietary Nitrate/Nitrite as Sources of Bioactive Nitric Oxide in Patients with Coronary Artery Disease

 03-H-0282:

Characterization of Cardiac Function in Patients with Hereditary Hemochromatosis Who Are New York Heart Association Functional Class I

 03-H-0219:

A Genome-Wide Scan for Quantitative Trait Loci of Hematocrit - A Framingham Study

 03-H-0201:

Cytokine Gene Polymorphisms in Allotransplant Donors

 03-H-0193:

A Randomized Trial of a Novel Immunosuppressive Combination of ATG, CsA and Sirolimus (Rapamune) vs a Slow Taper Cyclosporine Regimen in Subjects with Severe Aplastic Anemia

 03-H-0192:

Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-back for Hematological Malignancies - Effect of Irradiated Donor Lymphocytes on Chimerism

 02-H-0265:

Identification of Genes Expressed in Atherosclerotic Plaques

 02-H-0111:

Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Role of Preparative Regimen and T Cell Dose in Graft Rejection and GVHD

 01-H-0223:

Inhaled Nitric Oxide and Transfusion Therapy for Patients with Sickle Cell Anemia and Secondary Pulmonary Hypertension

 01-H-0162:

Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Utilizing RFT5-SMPT-dgA, a Specific Anti-Interleukin-2 Receptor Immunotoxin: Reducing GVHD Risk Associated with HLA-Matched, Nonmyeloablative, Peripheral Blood Stem Cell Transplantation for

 01-H-0031:

National Heart, Lung, and Blood Institute Data Distribution

 00-H-0169:

A Phase II Study of Antithymocyte Globulin (ATG) and Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

 00-H-0032:

Treatment of Severe Aplastic Anemia with Combined Immunosuppression: Antithymocyte Globulin (ATG) and Cyclosporine A (CSA), and Mycophenolate Mofetil (MMF)

 99-H-0064:

Exploratory Study of Non-Myeloablative Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusions for Metastatic Neoplasms Refractory to Standard Therapy

 99-H-0046:

Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine

 97-H-0202:

Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults

 97-H-0130:

Collection of Blood and Bone Marrow from Normal Volunteers and Patients for Research Purposes

 97-H-0117:

A Randomized Trial of Antithymocyte Globulin and Cyclosporine versus Cyclophosphamide and Cyclosporine in the Treatment of Severe Aplastic Anemia

 97-H-0099:

HLA-Matched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies

 95-H-0167:

Effect of Hypoxia and Smoking on Oxidation of Proteins and Nucleic Acids in Human Volunteers

 94-H-0033:

Retroviral Mediated Gene Transfer of the Fanconi Anemia Complementation Group C Gene to Hematopoietic Progenitors of Group C Patients

 86-H-0088:

Lymphocytapheresis of Patients with Pancytopenia

 85-H-0105:

Cardiovascular Evaluation of Homozygous Familial Hypercholesterolemia

 85-H-0087:

Clinical Course of Patients with Transfusional Hemochromatosis on Deferoxamine

 84-H-0029:

Effect of Hydroxyurea on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

Previous 100 Protocols

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home

National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 01/30/2009